Soleno Therapeutics (SLNO) Capital Expenditures Growth (1y) (2016 - 2025)
Soleno Therapeutics (SLNO) Capital Expenditures Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 143.40% |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 625.00% |
| Sep 30, 2025 | -99.48% |
| Jun 30, 2025 | 75.00% |
| Dec 31, 2022 | -153.85% |
| Dec 31, 2021 | 750.00% |
| Dec 31, 2020 | -140.00% |
| Dec 31, 2019 | 150.00% |
| Dec 31, 2018 | 100.35% |
| Sep 30, 2018 | -99.12% |
| Dec 31, 2017 | -1,569.35% |
| Sep 30, 2017 | 1,865.52% |
| Jun 30, 2017 | -200.00% |
| Mar 31, 2017 | -78.95% |
| Dec 31, 2016 | 84.71% |
| Sep 30, 2016 | -89.79% |
| Jun 30, 2016 | -93.75% |